| 1783 Stock | | | TWD 52.30 0.60 1.16% |
Maxigen Biotech
fundamentals help investors to digest information that contributes to Maxigen Biotech's financial success or failures. It also enables traders to predict the movement of Maxigen Stock. The
fundamental analysis module provides a way to measure
Maxigen Biotech's intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various
microeconomic indicators and financial ratios related to Maxigen Biotech stock.
This module does not cover all equities due to inconsistencies in global equity categorizations. Continue to
Equity Screeners to view more equity screening tools.
Maxigen Biotech Company Year To Date Return Analysis
Maxigen Biotech's Year to Date Return (YTD) is the total return generated from holding a security from the beginning of the current fiscal year. In other words, YTD Return represents the capital appreciation of your investments from the start of the current fiscal year.
Year-To-Date typically refers to a period starting from the beginning of the current year and continuing up to the present day. Investors should becareful when comparing YTD ratios if not much of the year has occurred as research shows that YTD measures are more sensitive to early periods than late.
In accordance with the company's disclosures, Maxigen Biotech has a Year To Date Return of 0.0%. This indicator is about the same for the Healthcare average (which is currently at 0.0) sector and about the same as
Drug Manufacturers - Major (which currently averages 0.0) industry. This indicator is about the same for all Taiwan stocks average (which is currently at 0.0).
| | Idea BreakdownAnalyze constituents of all Macroaxis ideas. Macroaxis investment ideas are predefined, sector-focused investing themes |
Maxigen Fundamentals
About Maxigen Biotech Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Maxigen Biotech's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Maxigen Biotech using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at
the intrinsic value of Maxigen Biotech based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing
financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.Additional Tools for Maxigen Stock Analysis
When running Maxigen Biotech's price analysis, check to
measure Maxigen Biotech's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Maxigen Biotech is operating at the current time. Most of Maxigen Biotech's value examination focuses on studying past and present price action to
predict the probability of Maxigen Biotech's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Maxigen Biotech's price. Additionally, you may evaluate how the addition of Maxigen Biotech to your portfolios can decrease your overall portfolio volatility.